First-quarter earnings were largely wiped out by a $6.9 billion charge tied to litigation and other costs from its Covid-19 vaccine commitments.
Source link
Johnson & Johnson Posts Higher Quarterly Sales, Raises 2023 Outlook
![Johnson & Johnson Posts Higher Quarterly Sales, Raises 2023 Outlook](http://www.nasdaqpicks.com/wp-content/uploads/2023/04/Johnson-amp-Johnson-Posts-Higher-Quarterly-Sales-Raises-2023-Outlook-1200x640.jpeg)
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
First-quarter earnings were largely wiped out by a $6.9 billion charge tied to litigation and other costs from its Covid-19 vaccine commitments.
Source link